文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

院内心脏骤停接受体外心肺复苏后良好预后的预测因素:系统评价与Meta分析

Predictors of favourable outcome after in-hospital cardiac arrest treated with extracorporeal cardiopulmonary resuscitation: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2017-10-08
一句话结论成人院内心脏骤停行ECPR后,初始可除颤心律、更短低灌注时间、更低乳酸、更低SOFA评分及24小时内更低肌酐与存活出院相关。

该系统评价与Meta分析纳入11项研究共856例成人院内心脏骤停接受ECPR的患者,其中324例(37.9%)存活出院,存活者中222/263例(84.4%)神经功能良好(CPC 1或2)。存活与初始可除颤心律(OR 1.65;95%CI 1.05-2.61;p=0.03)、更短低灌注时间(PMD -17.15 [-20.90, -13.40]分钟;p<0.00001)、ECPR启动前更低乳酸(PMD -4.12 [-6.0, -2.24]mmol/L;p<0.0001)及ICU入院时更低乳酸(PMD -4.13 [-6.38, -1.88]mmol/L;p<0.0003)、更低SOFA评分(PMD -1.71 [-2.93, -0.50];p=0.006)、ICU入院24小时内更低肌酐(PMD -0.37 [-0.54, -0.19]mg/dl;p<0.00001)相关。年龄、性别、心脏与非心脏病因与存活无显著关联。总体证据质量(GRADE)为低或极低。

要点

  • 成人院内心脏骤停ECPR后存活出院率为37.9%(324/856),存活者中84.4%(222/263)神经功能良好(CPC 1或2)。
  • 初始可除颤心律与存活出院相关(OR 1.65;95%CI 1.05-2.61;p=0.03)。
  • 低灌注时间更短与存活相关(PMD -17.15分钟;95%CI -20.90至-13.40;p<0.00001)。
  • ECPR启动前乳酸更低(PMD -4.12 mmol/L;95%CI -6.0至-2.24;p<0.0001)及ICU入院时乳酸更低(PMD -4.13 mmol/L;95%CI -6.38至-1.88;p<0.0003)与存活相关。
  • SOFA评分更低(PMD -1.71;95%CI -2.93至-0.50;p=0.006)及ICU入院24小时内肌酐更低(PMD -0.37 mg/dl;95%CI -0.54至-0.19;p<0.00001)与存活相关;年龄、性别、心脏与非心脏病因与存活无显著关联。

适用人群与场景

  • 成人院内心脏骤停(IHCA)接受体外心肺复苏(ECPR)复苏的患者。

研究设计与关键结果

  • 系统评价与Meta分析,纳入11项研究共856例成人IHCA接受ECPR的患者,324例(37.9%)存活出院。
  • 存活者中222/263例(84.4%)神经功能良好(CPC 1或2)。
  • 存活与初始可除颤心律相关(OR 1.65;95%CI 1.05-2.61;p=0.03)。
  • 存活与更短低灌注时间相关(PMD -17.15分钟;95%CI -20.90至-13.40;p<0.00001)。
  • 存活与ECPR启动前更低乳酸相关(PMD -4.12 mmol/L;95%CI -6.0至-2.24;p<0.0001),与ICU入院时更低乳酸相关(PMD -4.13 mmol/L;95%CI -6.38至-1.88;p<0.0003)。
  • 存活与更低SOFA评分相关(PMD -1.71;95%CI -2.93至-0.50;p=0.006)。
  • 存活与ICU入院24小时内更低肌酐相关(PMD -0.37 mg/dl;95%CI -0.54至-0.19;p<0.00001)。
  • 年龄、性别、心脏与非心脏病因与存活无显著关联。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析;证据质量按GRADE评估,总体为低或极低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,初始可除颤心律、更短低灌注时间、ECPR启动前或ICU入院时更低乳酸、更低SOFA评分及ICU入院24小时内更低肌酐这些因素可帮助识别适合ECPR的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: To identify the predictors of survival to discharge in adults resuscitated with extracorporeal cardiopulmonary resuscitation (ECPR) following in-hospital cardiac arrest (IHCA).

METHODS: MEDLINE and ISI Web of Science were searched for eligible studies. Pooled Odds Ratio (OR) and Pooled Mean Difference (PMD) for each predictor were calculated. The quality of evidence (QOE) was evaluated according to the GRADE guidelines.

RESULTS: Eleven studies were included totalling 856 patients. Of these, 324 (37.9%) survived to discharge. Good neurological outcome (Cerebral Performance Category 1 or 2) occurred in 222/263 (84.4%) survivors. Survival was associated with significantly higher odds of an initial shockable rhythm (OR 1.65; 95% confidence interval [95%CI] 1.05-2.61; p=0.03), shorter low-flow time (PMD -17.15 [-20.90, -13.40]min; p<0.00001), lower lactate levels both immediately before ECPR start (PMD -4.12 [-6.0,-2.24]mmol/L; p<0.0001) and on ICU admission (PMD -4.13 [-6.38, -1.88]mmol/L; p<0.0003), lower SOFA score (PMD -1.71 [-2.93, -0.50]; p=0.006) and lower creatinine levels within 24h after ICU admission (PMD -0.37 [-0.54, -0.19]mg/dl; p<0.00001). No significant association was found between survival and age, gender, or cardiac vs. non-cardiac aetiology. The overall QOE was low or very low.

CONCLUSIONS: In adult IHCA treated with ECPR a shockable initial rhythm, a lower low-flow time, lower blood lactate levels before ECPR start or on ICU admission, and a lower SOFA score or creatinine levels in the first 24h after ICU admission were associated with a higher likelihood of survival. These factors could help identifying patients who are eligible for ECPR.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. D'Arrigo S, Cacciola S, Dennis M, et al. Predictors of favourable outcome after in-hospital cardiac arrest treated with extracorporeal cardiopulmonary resuscitation: A systematic review and meta-analysis. Resuscitation. 2017. PMID: 29020604. doi:10.1016/j.resuscitation.2017.10.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。